Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

JAMA Netw Open. 2020 Aug 3;3(8):e2017708. doi: 10.1001/jamanetworkopen.2020.17708.

Abstract

This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus
  • Bradykinin / analogs & derivatives*
  • Bradykinin / metabolism*
  • Bradykinin / therapeutic use
  • Bradykinin B2 Receptor Antagonists / therapeutic use*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / metabolism
  • Coronavirus Infections / virology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxygen / blood
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / metabolism
  • Pneumonia, Viral / virology
  • Receptor, Bradykinin B2 / metabolism*
  • SARS-CoV-2

Substances

  • Bradykinin B2 Receptor Antagonists
  • Receptor, Bradykinin B2
  • icatibant
  • Oxygen
  • Bradykinin